Condition

APL clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Early use of oral Realgar-Indigo Naturalis plus all-trans retinoic acid for acute promyelocytic leukemia

  This study will test whether starting an oral arsenic medicine called Realgar-Indigo Naturalis Formula (RIF) together with all-trans retinoic acid (ATRA) early in treatment can lower early deaths in adults with acute promyelocytic leukemia (APL).

  Recruiting Phase 3 First Affiliated Hospital Xi'an Jiaotong University · Xi'an, Shaanxi · NCT07503730

• Combining Chidamide and Venetoclax for Hard-to-Treat Acute Promyelocytic Leukemia

  This study is testing a new combination of two drugs, chidamide and venetoclax, to see if it can help people with hard-to-treat acute promyelocytic leukemia who haven't responded to standard treatments.

  Recruiting at 2 sites Phase 2 Shanghai Jiao Tong University School of Medicine · Huai'an, Jiangsu and 4 other locations · NCT05881265

Quick answers

How many APL clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →